Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1545 of 6351
-
New hope for endometriosis sufferers: drug trial targets pelvic pain
Symptom relief Recruiting nowThe main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).
Phase 2 • Sponsor: Gesynta Pharma AB • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
AI tailors sleep apnea therapy; app boosts exercise adherence
Disease control Recruiting nowThis study aims to improve treatment strategies for Obstructive Sleep Apnea (OSA), a disorder characterized by recurrent upper airway collapse during sleep, resulting in reduced oxygenation, sleep fragmentation, and excessive daytime sleepiness. The objectives are twofold: to eva…
Sponsor: National Cheng-Kung University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New rapid test could save lives from toxic chinese herb poisoning
Diagnosis Recruiting nowAconitine and related alkaloids are potent cardiotoxins and neurotoxins found in the Aconitum species used in traditional Chinese medicine (TCM), such as 'Chuanwu', 'Caowu' and 'Fuzi'. They pose significant health risks when used inappropriately without professional supervision. …
Sponsor: The University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 11:01 UTC
-
Can community action and cash help end violence against women? malawi trial aims to find out
Prevention Recruiting nowViolence against women is complex and must be addressed at multiple levels, with leadership from women themselves on how to bring about positive change to free women and girls from daily experiences of violence and to promote their rights. It is in this context that the Pamodzi K…
Sponsor: George Washington University • Aim: Prevention
Last updated Jun 27, 2026 12:03 UTC
-
Fasting two days a week could shrink fatty liver, new study hopes to prove
Disease control Recruiting nowThe recommended treatment for metabolic dysfunction-associated steatotic liver disease (MASLD) currently focuses on lifestyle changes, including dietary adjustments and increased physical activity. Intermittent fasting is a specific dietary approach in which food intake is restri…
Sponsor: Universität des Saarlandes • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New cell therapy for MS enters human safety testing
Disease control OngoingThis study aims to explore the safety, tolerability, cellular kinetics, and pharmacodynamics of P-CD19CD20-ALLO1 in participants with progressive multiple sclerosis (PMS) and relapsing multiple sclerosis (RMS).
Phase 1 • Sponsor: Genentech, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
A simple nesting technique might soothe newborns during shots
Symptom relief Recruiting nowThis randomized controlled trial aims to evaluate the effect of nesting during the first intramuscular injection on pain, stress level, physiological parameters, settling time, and breastfeeding success in healthy term newborns delivered by cesarean section. A total of 112 newbor…
Sponsor: Istanbul University - Cerrahpasa • Aim: Symptom relief
Last updated Aug 07, 2026 00:00 UTC
-
New drug combo aims to fight Hard-to-Treat cancers
Disease control Not yet recruitingThis is a Phase 1, open-label, dose-escalation and cohort expansion study designed to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of IMM2510(Anti-PD-L1 and VEGF trap recombinant protein) combine with IMM01(Anti-CD47 Recombinant Protein)…
Phase 1/2 • Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc. • Aim: Disease control
Last updated Jun 26, 2026 15:39 UTC
-
Brain zaps aim to unlock better walking for MS patients
Symptom relief Recruiting nowStudy the impact of rTMS on walking ability in people with Multiple Sclerosis (MS) induced spastic paraparesis and moderate walking disability.
Sponsor: Clinique Neuro-Outaouais • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
AI reads baby brain scans: could it spot problems doctors miss?
Diagnosis OngoingTimely detection of fetal brain anomalies is critical for improving prenatal counseling and postnatal neurological outcomes. Ultrasonography is the most commonly used and effective imaging method for evaluating fetal structures; however, diagnostic accuracy can be affected by ope…
Sponsor: Sanliurfa Mehmet Akif Inan Education and Research Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 08:00 UTC
-
New hope for cervical cancer? drug cocktail targets tumors that resist immunotherapy
Disease control Not yet recruitingThis is a clinical research study for women with recurrent or metastatic cervical cancer whose disease has progressed after prior treatment with a PD-1/PD-L1 inhibitor immunotherapy. The study will evaluate the effectiveness and safety of a new combination treatment consisting o…
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New drug before prostate surgery aims to wipe out hidden cancer cells
Disease control Not yet recruitingReal-world study on Preoperative Application of Rezvilutamide
Sponsor: Shanghai Pudong New Area Gongli Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
AI-Powered home rehab could transform stroke recovery
Symptom relief Recruiting nowThe AISN multicenter randomized controlled trial will assess the effectiveness of a novel artificial intelligence (AI)-based clinical decision-support system integrated into the Rehabilitation Gaming System (RGS) for home-based post-stroke rehabilitation. Approximately 192 partic…
Sponsor: Eodyne Systems SL • Aim: Symptom relief
Last updated Jun 27, 2026 08:06 UTC
-
Electric field device takes on pancreatic cancer in new trial
Disease control Recruiting nowThe purpose of this clinical trial is to assess the safety and tolerability of TTFields in combination with chemotherapy in adults with metastatic pancreatic adenocarcinoma based on treatment-emergent adverse events of chemotherapy (modFOLFIRINOX) or device (TTFields). The main …
Phase 1/2 • Sponsor: Clinica Universidad de Navarra, Universidad de Navarra • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Engineered immune cells take on autoimmune diseases in early trial
Disease control Recruiting nowThis is a prospective, single-arm, open-label and dose-escalation Investigator Initialed study to evaluate LUCAR-DKS1 in adult subjects with relapsed/refractory autoimmune diseases.
Early phase 1 • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New blood test could spot deadly lung clots faster
Diagnosis Not yet recruitingIn response to the high mortality rate of patients with acute pulmonary embolism (APE) and the fact that only a small proportion of deceased patients can receive correct diagnosis, this study will use a sensitive, non-invasive, and feasible new thrombus molecular marker (TAT/PIC/…
Sponsor: Beijing Anzhen Hospital • Aim: Diagnosis
Last updated Jun 26, 2026 18:36 UTC
-
Double radiation attack may slow tough gut tumors
Disease control Recruiting nowThis phase I trial tests the safety and effectiveness of stereotactic body radiation therapy (SBRT) followed by 177Lu-DOTATATE peptide receptor radionuclide therapy (PRRT) in treating patients with large well-differentiated grade 1-2 digestive system neuroendocrine tumors that ca…
Phase 1 • Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Could a lower dose of this thyroid cancer drug be just as good?
Disease control Recruiting nowThis open-label, randomized phase II trial evaluates the dose delivery, tolerance, and efficacy of two dosing regimens of lenvatinib among patients with radioactive iodine resistant (RAIR) differentiated thyroid cancer (DTC).
Phase 2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Bird flu vaccine study: does timing matter?
Vaccine OngoingGiven the recent circulation of avian influenza A(H5N1) clade 2.3.4.4b strains in birds and mammals in North America, Canada procured a supply of Arepanrix™ H5N1 for potential use in persons at high risk of highly pathogenic avian influenza exposure. This vaccine received regula…
Phase 4 • Sponsor: Canadian Immunization Research Network • Aim: Vaccine
Last updated Jun 27, 2026 08:11 UTC
-
New peptide drug hopes to boost brain repair after stroke
Disease control Recruiting nowThis is a randomized, double-blinded, placebo-controlled study investigating the safety and efficacy of QD202 injection in patients with acute ischemic stroke undergoing thrombolysis excluding endovascular thrombectomy. Up to 120 male and female patients with acute ischemic strok…
Phase 2 • Sponsor: Shanghai QuietD Biotechnology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC